dc.contributor.author | Sack, David A | en |
dc.contributor.author | Lyke, Christine | en |
dc.contributor.author | McLaughlin, Carol | en |
dc.contributor.author | Suwanvanichkij, Voravit | en |
dc.contributor.author | World Health Organization. Anti-Infective Drug Resistance Surveillance and Containment Team | en |
dc.coverage.spatial | Geneva | |
dc.date.accessioned | 2012-06-17T00:33:33Z | |
dc.date.available | 2012-06-17T00:33:33Z | |
dc.date.created | 2001 | en |
dc.date.issued | 2001 | en |
dc.identifier.govdoc | WHO/CDS/CSR/DRS/2001.8 | en |
dc.identifier.uri | https://iris.who.int/handle/10665/66875 | |
dc.description | A background document for the WHO global strategy for containment of antimicrobial resistance | en |
dc.description | WHO/CDS/CSR/DRS/2001.8 | en |
dc.description | 51 p. | en |
dc.language.iso | en | en |
dc.publisher | World Health Organization | |
dc.publisher | World Health Organization | |
dc.subject.mesh | Drug Resistance, Microbial | en |
dc.subject.mesh | Shigella | en |
dc.subject.mesh | Vibrio cholerae | en |
dc.subject.mesh | Campylobacter jejuni | en |
dc.subject.mesh | Enterobacteriaceae | en |
dc.subject.other | Communicable Diseases and their Control | en |
dc.title | Antimicrobial resistance in shigellosis, cholera and campylobacteriosis / David A. Sack ... [et al.] | en |
dc.subject.meshqualifier | drug therapy | en |
dc.subject.meshqualifier | drug effects | en |